Cidara Therapeutics, Inc.: Nasdaq/NYSE listing notice — Cidara receives Nasdaq delisting notice for bid price below $1.00; requests hearing

Cidara Therapeutics, Inc.

Nasdaq notified Cidara on Nov 9, 2023 that bid price closed below $1.00 for 30 consecutive trading days.
Company is not eligible for compliance period due to prior Panel Monitor imposed by Nasdaq.
Cidara requested a hearing on Nov 16, 2023 to present a compliance plan and seek additional time.
Hearing request stays delisting action until Panel renders a decision.
No assurance that Panel will grant the requested 180-day extension or the hearing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Cidara Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

November 9, 2023, Cidara Therapeutics, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualification Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that for 30 consecutive trading days preceding November 6, 2023, the bid price of the Company’s common stock had closed below the $1.00 per share minimum required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). As a result of the Nasdaq Hearings Panel (the “Panel”) imposing the previously discl

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001610618-23-000102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.